These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 34555287

  • 1. Asthma and COPD medicines prescription-claims: A time-series analysis of England's national prescriptions during the COVID-19 pandemic (Jan 2019 to Oct 2020).
    Barrett R, Barrett R.
    Expert Rev Respir Med; 2021 Dec; 15(12):1605-1612. PubMed ID: 34555287
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study.
    Aveyard P, Gao M, Lindson N, Hartmann-Boyce J, Watkinson P, Young D, Coupland CAC, Tan PS, Clift AK, Harrison D, Gould DW, Pavord ID, Hippisley-Cox J.
    Lancet Respir Med; 2021 Aug; 9(8):909-923. PubMed ID: 33812494
    [Abstract] [Full Text] [Related]

  • 4. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ, Keating GM.
    Treat Respir Med; 2004 Aug; 3(4):247-68. PubMed ID: 15350163
    [Abstract] [Full Text] [Related]

  • 5. Prescription practices for chronic obstructive pulmonary disease: findings from the national ambulatory medical care survey 1999-2010.
    Ford ES, Mannino DM, Giles WH, Wheaton AG, Liu Y, Croft JB.
    COPD; 2014 Jun; 11(3):247-55. PubMed ID: 24568285
    [Abstract] [Full Text] [Related]

  • 6. Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.
    Dalal AA, Roberts MH, Petersen HV, Blanchette CM, Mapel DW.
    Int J Chron Obstruct Pulmon Dis; 2010 Dec 31; 6():13-22. PubMed ID: 21311689
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL, Akazawa M, Johnsrud M, Stanford RH, Blanchette CM.
    Clin Ther; 2007 Jun 31; 29(6):1203-13. PubMed ID: 17692734
    [Abstract] [Full Text] [Related]

  • 9. Comparison of tiotropium bromide and combined ipratropium/salbutamol for the treatment of COPD: a UK General Practice Research Database 12-month follow-up study.
    Griffin J, Lee S, Caiado M, Kesten S, Price D.
    Prim Care Respir J; 2008 Jun 31; 17(2):104-10. PubMed ID: 18385913
    [Abstract] [Full Text] [Related]

  • 10. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease.
    Cramer JA, Bradley-Kennedy C, Scalera A.
    Can Respir J; 2007 Jun 31; 14(1):25-9. PubMed ID: 17315055
    [Abstract] [Full Text] [Related]

  • 11. Calcineurin inhibitors and related medicines: a cohort study examining England's primary care prescription changes during the COVID-19 pandemic (January 2019 to March 2021).
    Barrett R.
    Daru; 2022 Jun 31; 30(1):59-66. PubMed ID: 35075618
    [Abstract] [Full Text] [Related]

  • 12. Prescribing Patterns and Treatment Adherence in Patients with Asthma During the COVID-19 Pandemic.
    Dhruve H, d'Ancona G, Holmes S, Dhariwal J, Nanzer AM, Jackson DJ.
    J Allergy Clin Immunol Pract; 2022 Jan 31; 10(1):100-107.e2. PubMed ID: 34610490
    [Abstract] [Full Text] [Related]

  • 13. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
    Lee TA, Schumock GT, Bartle B, Pickard AS.
    Pharmacotherapy; 2009 Sep 31; 29(9):1039-53. PubMed ID: 19698009
    [Abstract] [Full Text] [Related]

  • 14. Is there any association between inhaled ipratropium and mortality in patients with COPD and asthma?
    Ringbaek T, Viskum K.
    Respir Med; 2003 Mar 31; 97(3):264-72. PubMed ID: 12645834
    [Abstract] [Full Text] [Related]

  • 15. Bronchodilation and safety of supratherapeutic doses of salbutamol or ipratropium bromide added to single dose GSK961081 in patients with moderate to severe COPD.
    Norris V, Ambery C.
    Pulm Pharmacol Ther; 2013 Oct 31; 26(5):574-80. PubMed ID: 23524017
    [Abstract] [Full Text] [Related]

  • 16. Impact of abolishing prescription fees in Scotland on hospital admissions and prescribed medicines: an interrupted time series evaluation.
    Williams AJ, Henley W, Frank J.
    BMJ Open; 2018 Dec 18; 8(12):e021318. PubMed ID: 30567818
    [Abstract] [Full Text] [Related]

  • 17. [Effects of salbutamol and ipratropium bromide on arterial blood gases in patients with stable COPD].
    Ozdemir T, Geçkin E, Oğüş C, Cilli A.
    Tuberk Toraks; 2003 Dec 18; 51(2):132-7. PubMed ID: 15143418
    [Abstract] [Full Text] [Related]

  • 18. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B, Markham A.
    Drugs Aging; 2001 Dec 18; 18(6):441-72. PubMed ID: 11419918
    [Abstract] [Full Text] [Related]

  • 19. Medication prescribing for asthma and COPD: a register-based cross-sectional study in Swedish primary care.
    Weidinger P, Nilsson JL, Lindblad U.
    BMC Fam Pract; 2014 Mar 25; 15():54. PubMed ID: 24666507
    [Abstract] [Full Text] [Related]

  • 20. Ipratropium treatment of acute airways disease.
    Peterson GM, Boyles PJ, Bleasel MD, Vial JH.
    Ann Pharmacother; 2003 Mar 25; 37(3):339-44. PubMed ID: 12639159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.